Full Transparency
Our editorial transparency tool uses blockchain technology to permanently log all changes made to official releases after publication.
More of our content is being permanently logged via blockchain technology starting [10.23.2020].
Troubled by the rising rates of diabetes, Dr. Jonathan Javitt, John Dwyer and David Bjork joined forces to create Telcare, a Bethesda, Md.-based company that is transforming the way patients manage their diabetes.
Although small in size, the company has a large mission: harness wireless technology in order to empower patients, caregivers and doctors with the tools needed to manage the illness in real time.
More than 100 million people suffer from diabetes, 28 million of whom reside in the U.S. And according to a report released by the CDC, if current trends continue, one in three Americans will have Type 2 diabetes by the year 2050.
"The statistics are alarming, as diabetes already contributes to tens of thousands of deaths annually and costs the country an estimated $300 billion a year," said Dr. Javitt. "We’ve launched a glucose monitoring solution that is poised to improve outcomes and help patients better monitor this chronic disease."
Dr. Javitt said Telcare’s Blood Glucose Meter (BGM) is an FDA-approved wireless-enabled meter that delivers real-time data to patients and their care team. Now, parents can spend less time worrying about their child at school and if there will be an unexpected trip to the hospital.
The BGM is a stand-alone wireless device that uses machine-to-machine (M2M) technology over the Verizon Wireless network to create a connected care environment and provide quick results and coaching or feedback through personalized messages. This connected care environment also allows patients to use free mobile apps through their iOS and Android devices.
Now, it’s easy to create and obtain goals, communicate with caregivers and track medication and nutrition information. The future of disease management is here.
